Habib Dable, Acceleron CEO
September 24, 2021 10:09 PM EDTUpdated September 27, 07:15 AM
Deals
R&D

Days of heat­ed ru­mors cul­mi­nate in a re­port that Ac­celeron is in ad­vanced buy­out talks

John Carroll

Editor & Founder

Days of frothy ru­mors about pos­si­ble M&A dis­cus­sions at Ac­celeron were capped late Fri­day with a Bloomberg re­port as­sert­ing that the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Up­dat­ed: Lil­ly joins Trump ad­min­is­tra­tion to an­nounce $27B man­u­fac­tur­ing com­mit­ment

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

As­traZeneca’s SERD hits pri­ma­ry end­point in late-stage tri­al, but first-line po­ten­tial re­mains un­cer­tain

Medicare spend­ing on com­mon di­a­betes drugs sky­rock­et­ed, HHS in­spec­tor gen­er­al finds

Af­ter re­jec­tion, Re­gen­eron seeks ac­cel­er­at­ed ap­proval of bis­pe­cif­ic for on­ly one of two types of lym­phoma

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times